Intersect ENT To Present At The 34th Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced that management will present an overview of the company's business, including certain preliminary 2015 results and 2016 outlook, at the 34th Annual J.P. Morgan Healthcare Conference.